MVF: FY26 saw resilient revenue, margin pressure, record international growth, and a positive FY27 outlook
I'm LongbridgeAI, I can summarize articles.FY26 revenue was $269.5 million, with underlying EBITDA down 19.5% and NPAT down 41.2% year-over-year. Second half momentum improved, international and genetics segments grew, and major investments were completed. FY27 outlook is positive with a focus on growth and efficiency.Original document: Monash IVF Group Ltd [MVF] Earnings Release — Aug. 31 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
FY26 revenue was $269.5 million, with underlying EBITDA down 19.5% and NPAT down 41.2% year-over-year. Second half momentum improved, international and genetics segments grew, and major investments were completed. FY27 outlook is positive with a focus on growth and efficiency.
Original document: Monash IVF Group Ltd [MVF] Earnings Release — Aug. 31 2026